Houston Continuing Medical Education Conference

Pri-Med Southwest - Primary Care CME/CE Conference & Expo

Houston, TX | April 5-7, 2022

George R. Brown Convention Center

Explore Online CME Agenda

Disclosures

The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.

Financial Disclosures

Martin J. Abrahamson, MD, FACP: Novo Nordisk, Advisor

Charles E. Argoff, MD, FABPM: AbbVie, Researcher; AbbVie, Speaker; Allergan, Researcher; Amgen, Advisor; Amgen, Researcher; Amgen, Speaker; BioDelivery Sciences International, Inc., Advisor; Biohaven, Speaker; Biohaven, Speaker; Clexio Biosciences, Advisor; Collegium, Other; EnZen Therapeutics, Consultant; Lilly, Researcher; Lilly, Speaker; Lundbeck, Researcher; Neumentum, Advisor; Nevro, Advisor; Nevro, Speaker; Opioid PMR Consortium, Consultant; Redhill Pharma, Speaker; Regeneron Pharmaceuticals, Advisor; SK Life Sciences, Advisor; Teva, Researcher; Teva, Speaker; Teva Pharmaceuticals, Advisor; Tremeau Pharmaceuticals, Inc., Advisor; Vertex, Advisor; XGene Pharma, Consultant

Robert L. Atmar, MD: Takeda Vaccines, Inc., Researcher

Christie M. Ballantyne, MD, FACP, FACC: Althera, Consultant; Amarin Pharma, Inc., Consultant; Arrowhead, Consultant; Arrowhead, Consultant; Arrowhead, Researcher; Astra Zeneca, Consultant; Esperion, Consultant; Genentech, Consultant; Gilead, Consultant; Ionis, Researcher; Matinas BioPharma Inc., Consultant; Merck, Consultant; New Amsterdam, Consultant; Novartis, Consultant; Novartis, Researcher; Novo Nordisk, Consultant; Novo Nordisk, Researcher; Pfizer, Consultant; Sanofi-Synthelabo, Consultant

Lauren S. Blieden, MD: Aerie Pharmaceuticals, Advisor; Allergan, Inc., Advisor

Angela Catic, MD, MEd: No relevant financial relationships disclosed.

Sanjiv Chopra, MD, MACP: No relevant financial relationships disclosed.

Armando G. Correa, MD, FAAP: No relevant financial relationships disclosed.

Oscar A. de Leon-Casasola, MD: Esteve Pharma, Advisor; Heron Therapeutics, Advisor; Medtronic, Advisor; Tremeau Pharma, Advisor

Frank J. Domino, MD: No relevant financial relationships disclosed.

Hana El Sahly, MD: No relevant financial relationships disclosed.

Katherine E. Galluzzi, DO, CMD, FACOFP: No relevant financial relationships disclosed.

Ty J. Gluckman, MD, FACC, FAHA: No relevant financial relationships disclosed.

Jennifer B. Green, MD: AstraZeneca, Consultant; Bayer, Consultant; Boehringer Ingelheim/Lilly, Consultant; Boehringer Ingelheim/Lilly, Researcher; Hawthorn Effect/Omada, Consultant; Merck & Co. Inc., Researcher; Novo Nordisk, Inc., Consultant; Pfizer, Consultant; Roche, Researcher; Sanofi/Lexicon, Consultant; Sanofi/Lexicon, Researcher

Stephen N. Henry, DO, MS: No relevant financial relationships disclosed.

Prathit A. Kulkarni, MD: Vessel Health, Inc., Researcher

Anupam Kumar, MD, FCCP: No relevant financial relationships disclosed.

Doris Kung, DO: No relevant financial relationships disclosed.

Petros Levounis, MD, MA: No relevant financial relationships disclosed.

Marco Marcelli, MD: No relevant financial relationships disclosed.

Sanjay N. Mediwala, MD: No relevant financial relationships disclosed.

Travis Mills: No relevant financial relationships disclosed.

Dharani Narendra, MD: No relevant financial relationships disclosed

Saundra Nguyen, MD, MPH: No relevant financial relationships disclosed.

Jeffrey Rado, MD, MPH, FAPA: No relevant financial relationships disclosed.

Rajeev Raghavan, MD: Bayer, Speaker; Reata Pharmaceuticals, Inc., Advisor; Travere, Consultant

Vicky Ren, MD: No relevant financial relationships disclosed

R. Michelle Schmidt, MD, MPH: No relevant financial relationships disclosed.

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS: Boehringer Ingelheim Pharmaceuticals, Inc., Consultant; Calibrate, Advisor; Coral Health, Advisor; Gelesis, Consultant; GoodRx, Advisor; Lilly USA, LLC, Consultant; Novo Nordisk Inc., Consultant; Pfizer Inc., Consultant

Peter P. Toth, MD, PhD: Amarin Pharma Inc., Advisor; Kowa Pharmaceuticals America, Inc., Advisor; Novartis Pharmaceuticals Corporation, Advisor; Novo Nordisk, Speaker; Resverlogix, Advisor

Shirah Vollmer, MD: No relevant financial relationships disclosed.

Daniel Y. Wang, MD: Regeneron, Advisor; Sanofi-Genzyme, Advisor; Tessa Therapeutics, Researcher

Karol E. Watson, MD, PhD: Amarin Pharma Inc., Consultant; Amgen Inc., Consultant; Boehringer Ingelheim Pharmaceuticals, Inc., Consultant; Boehringer Ingelheim Pharmaceuticals, Inc., Speaker; Esperion Therapeutics, Consultant; Lilly USA, LLC, Consultant; Lilly USA, LLC, Speaker

Jennifer Whitaker, MD, MS: No relevant financial relationships disclosed.

Other Disclosures

Richard Hamill, MD (Course Co-Chair): Consultant with Moderna.

Pamela Kushner, MD, FAAFP (Reviewer): Speaker/Advisor/Consultant with AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Janssen, and Novo Nordisk. Speaker with Bayer. Advisor with Abbott, Intuity Medical, Phathom, and Pfizer. Stock Holder with Abbott, AstraZeneca, and Lilly.

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.